Advertisement

The United States, India and other nations around the world are facing a shortage of tuberculosis drugs. The Wall Street Journal’s Geeta Anand talks with Bobby John, head of Global Advocates, about finding possible solutions to fighting this deadly disease.

Advertisement
Advertisement